High loading of gentamicin in bioadhesive PVM/MA nanostructured microparticles using compressed carbon-dioxide

Pharmaceutical Research

Volumn 28, Issue 2, 2011, Pages 309-321

  Elizondo, Elisa ^a,b   Sala, Santiago ^a,b   Imbuluzqueta, Edurne ^c   González, David ^c   Blanco Prieto, María J ^c   Gamazo, Carlos ^c   Ventosa, Nora ^a,b   Veciana, Jaume ^a,b  

^a INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA ICMAB CSIC   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Gantrez AN; gentamicin; microparticles; PVM MA; supercritical fluids

Indexed keywords

ANIONIC SURFACTANT; CARBON DIOXIDE; GANTREZ COPOLYMER; GENTAMICIN; SULFATE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BIODEGRADABILITY; BRUCELLA MELITENSIS; CHEMICAL COMPOSITION; CHEMICAL INTERACTION; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG FORMULATION; ESCHERICHIA COLI; HYDROPHOBICITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NANOENCAPSULATION; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRECIPITATION; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

BRUCELLA; CARBON DIOXIDE; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; GENTAMICINS; KINETICS; MALEATES; NANOSTRUCTURES; PARTICLE SIZE; POLYETHYLENES;

EID: 79952485001     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0248-x     Document Type: Article

References (41)

1. Tabata Y, Gutta S, Langer R. Controlled delivery systems for proteins using polyanhydride microspheres. Pharm Res. 1993;10:487-96. (Pubitemid 23113038)
2. Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for controlled drug release. Chem Rev. 1999;99:3181-98. (Pubitemid 129583051)
3. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70:1-20. (Pubitemid 32144788)
4. Pridgen EM, Langer R, Farokhzad OC. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine. 2007;2:669-80. (Pubitemid 350268246)
5. de Campos AM, Diebold Y, Carvalho ELS, Sanchez A, Alonso MJ. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res. 2004;21:803-10. (Pubitemid 39011304)
6. O'Hara P, Hickey AJ. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization. Pharm Res. 2000;17:955-61.
7. Tracy MA. Development and scale-up of a microsphere protein delivery system. Biotechnol Prog. 1998;14:108-15. (Pubitemid 28118271)
8. Okada H. One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv Drug Deliv Rev. 1997;28:43-70. (Pubitemid 27497673)
9. Matson DW, Fulton JL, Petersen RC, Smith RD. Rapid expansion of supercritical fluid solutions: solute formation of powders, thin films and fibers. Ind Eng Chem Res. 1987;26:2298-306.
10. Gallagher PM, Coffey MP, Krukonis VJ, Klasutis N. Gas antisolvent recrystallization - new process to recrystallize compounds insoluble in supercritical fluids. ACS Symp Ser. 1989;406:334-54.
11. Bleich J, Müller BW, Wassmus W. Aerosol solvent extraction system-a new microparticle production technique. Int J Pharm. 1993;97:111-7. (Pubitemid 23242372)
12. Reverchon E. Supercritical antisolvent precipitation of micro- and nano-particles. J Supercrit Fluids. 1999;15:1-21. (Pubitemid 129671809)
13. Weidner E, Knez Z, Novak Z. PGSS (Particles from gas saturated solutions) - a new process for powder generation, Proceedings of the third International Symposium on Supercritical Fluids, France, 1994, pp. 229-234.
14. Ventosa N, Sala S, Veciana J, Llibre J, Torres J. Depressurization of an expanded organic liquid solution (DELOS): a new procedure for obtaining submicron- or micron-sized crystalling particles. Cryst Growth Des. 2001;1:299-303. (Pubitemid 33680421)
15. Bodmeier R, Wang H, Dixon DJ, Mawson S, Johnston KP. Polymeric microspheres prepared by spraying into compressed carbon-dioxide. Pharm Res. 1995;12:1211-7.
16. Yeo SD, Kiran E. Formation of polymer particles with supercritical fluids: a review. J Supercrit Fluids. 2005;34:287-308. (Pubitemid 40584247)
17. Mishima K. Biodegradable particle formation for drug and gene delivery using supercritical fluid and dense gas. Adv Drug Deliv Rev. 2008;60:411-32. (Pubitemid 351222677)
18. Reverchon E, Adami R, Cardea S, Della Porta G. Supercritical fluids processing of polymers for pharmaceutical and medical applications. J Supercrit Fluids. 2009;47:484-92.
19. 2 in a mixed solvent. Ind Eng Chem Res. 2001;40:795-800.
20. Ghaderi R, Artursson P, Carlfors J. A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in DL-PLG microparticles using supercritical fluids. Eur J Pharm Sci. 2000;10:1-9. (Pubitemid 30123139)
21. Arbós P, Campanero MA, Arangoa MA, Renedo MJ, Irache JM. Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties. J Control Release. 2003;89:19-30. (Pubitemid 36412111)
22. Arbós P, Campanero MA, Arangoa MA, Irache JM. Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines. J Control Release. 2004;96:55-65. (Pubitemid 38438489)
23. 12-gantrez nanoparticles. Pharm Res. 2008;25:2859-68.
24. Salman HH, Irache JM, Gamazo C. Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination. Vaccine. 2009;27:4784-90.
25. Irache JM, Salman HH, Gómez S, Espuelas S, Gamazo C. Poly (anhydride) nanoparticles as adjuvants for mucosal vaccination. Front Biosci. 2010 (in press).
26. Meyer JD, Falk RF, Kelly RM, Shively JE, Withrow SJ, Dernell WS, et al. Preparation and in vitro characterization of gentamycin-impregnated biodegradable beads suitable for treatment of osteomyelitis. J Pharm Sci. 1998;87:1149-54. (Pubitemid 28452118)
27. Virto MR, Elorza B, Torrado S, Elorza MA, Frutos G. Improvement of gentamicin poly(D, L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures. Biomaterials. 2007;28:877-85. (Pubitemid 44667024)
28. Lecaroz C, Gamazo C, Blanco-Prieto MJ. Nanocarriers with gentamicin to treat intracellular pathogens. J Nanosci Nanotechnol. 2006;6:3296-302. (Pubitemid 44580014)
29. Gamazo C, Prior S, Lecaroz MC, Vitas AI, Campanero MA, Pérez G, et al. Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections. Expert Opin Drug Deliv. 2007;4:677-88. (Pubitemid 350193402)
30. Falk R, Randolph TW, Meyer JD, Kelly RM, Manning MC. Controlled release of ionic compounds from poly(L-lactide) microspheres produced by precipitation with a compressed antisolvent. J Control Release. 1997;44:77-85. (Pubitemid 27051336)
31. Moreno E, Moriyon I. Brucella melitensis: A nasty bug with hidden credentials for virulence. Proc Natl Acad Sci USA. 2002;99:1-3. (Pubitemid 34060303)
32. Dixon DJ, Johnston KP, Bodmeier RA. Polymeric materials formed by precipitation with a compressed fluid antisolvent. AIChE J. 1993;39:127-39. (Pubitemid 266684)
33. Gimeno M, Ventosa N, Boumghar Y, Fournier J, Boucher I, Veciana J. Micronization of the chitosan derivatives D-glucosamine hydrochloride and D-glucosamine sulphate salts by dense gas antisolvent precipitation techniques. J Supercrit Fluids. 2006;38:94-102. (Pubitemid 44093201)
34. Blanco-Prieto MJ, Lecaroz C, Renedo MJ, Kunkova J, Gamazo C. In vitro evaluation of gentamicin released from microparticles. Int J Pharm. 2002;242:203-6.
35. Elizondo E, Ventosa N, Sala S, Veciana J, Blanco-Prieto MJ, Gamazo C, González D, Imbuluzqueta E. Composition comprising gentamicin, an anionic surfactant and a copolymer. WO Patent No 071730 A1, 11 June (2009).
36. Tantishaiyakul V,Kaewnopparat N, Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int J Pharm. 1999;181:143-51. (Pubitemid 29229801)
37. Corbel MJ. In: Young EJ, Corbel MJ, editors. Microbiology of the genus Brucella in Brucellosis: clinical and laboratory aspects. Boca Raton: CRC Press, Inc.; 1989. p. 53-72.
38. Elizondo E, Córdoba A, Sala S, Ventosa N, Veciana J. Preparation of biodegradable poly (methyl vinyl ether-co-maleic anhydride) nanostructured microparticles by precipitation with a compressed antisolvent. J Supercrit Fluids. 2010;53:108-114.
39. Lecaroz MC, Blanco-Prieto MJ, Campanero MA, Salman H, Gamazo C. Poly(D, L-Lactide-Coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice. Antimicrob Agents Chemother. 2007;51:1185-90. (Pubitemid 46586792)
40. Reverchon E, Antonacci A. Drug-polymer microparticles produced by supercritical assisted atomization. Biotechnol Bioeng. 2007;97:1626-37. (Pubitemid 47204040)
41. Lecároz C. Determination of gentamicin in different matrices by a new sensitive high-performance liquid chromatography-mass spectrometric method. J Antimicrob Chemother. 2006;58:557-63. (Pubitemid 44288119)